Vera Therapeutics Inc - Class A — Cash Flow (NASDAQ:VERA) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 23.71 M67.6 M92.18 M134.68 M241.1 M 241.1 M Cash from investing activities 4.2 M70.55 M39.43 M425.03 M194.29 M 194.29 M Cash from financing activities 53.88 M101.93 M133.54 M606.67 M308.9 M 308.9 M Free cash flow 23.71 M67.53 M92.12 M133.71 M240.47 M 240.47 M

ニュース

Vera Therapeutics: Hold Rating Based On Potential For Atacicept In IgAN (Rating Downgrade)

VeraDermics is said to draw IPO anchor order from Eli Lilly - Bloomberg

ベラ・セラピューティクス、マット・スケルトンを最高商業責任者に昇進

Vera Therapeutics promotes Matt Skelton to chief commercial officer

JPモルガン、ベラ・セラピューティクス株に対する「オーバーウェイト」評価を維持

JPMorgan reiterates Overweight rating on Vera Therapeutics stock

キャンター・フィッツジェラルド、ヴェラ・セラピューティクス株に対するオーバーウェイト評価を維持

Cantor Fitzgerald reiterates Overweight rating on Vera Therapeutics stock

Wall Street Analysts See a 53.05% Upside in Vera Therapeutics (VERA): Can the Stock Really Move This High?

Vera Therapeutics, Inc. (VERA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Vera Therapeutics社の株価上昇、FDAがアタシセプトのBLAを優先審査で受理

Vera Therapeutics stock rises after FDA accepts atacicept BLA with Priority Review